According to the new market research “Tissue
Diagnostics Market by
Product (Consumables, Instruments), Technology (Immunohistochemistry, in Situ
Hybridization, Digital Pathology & Workflow), Disease (Breast Cancer,
Gastric Cancer, Lymphoma), End User (Hospital, CRO) - Global Forecast to 2022",
analyzes and studies the major market drivers, restraints/challenges, and
opportunities. The tissue diagnostics market is expected to reach
USD 5.14 Billion by 2022 from USD 3.44 Billion in 2016 at a CAGR of 6.9%.
The global Tissue Diagnostics market is segmented based on
product, technology, disease,
end user and regions
By product, the market is segmented into instruments and
consumables. The consumables segment is estimated to account for the largest
market share of the global market in 2017. Factors driving the growth of this
segment include the widespread use of consumables and advances in technology to
develop novel consumables.
Download a PDF
Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1063949
Browse and in-depth TOC on in “Tissue Diagnostics Market
"
96 - Tables
40 - Figures
160 - Pages
By technology, the market is classified into immunohistochemistry, in situ hybridization, digital pathology and workflow, and special staining. The immunohistochemistry segment is estimated to account for the largest share of the global tissue diagnostics market during the next five years. Growth in the IVD (in vitro diagnostics) market and the large number of products based on this technology are driving the growth of this market.
96 - Tables
40 - Figures
160 - Pages
By technology, the market is classified into immunohistochemistry, in situ hybridization, digital pathology and workflow, and special staining. The immunohistochemistry segment is estimated to account for the largest share of the global tissue diagnostics market during the next five years. Growth in the IVD (in vitro diagnostics) market and the large number of products based on this technology are driving the growth of this market.
Request Free Sample
Report @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=1063949
https://www.marketsandmarkets.com/requestsampleNew.asp?id=1063949
On the basis of end user, the market is segmented into
hospitals, pharmaceutical companies, research laboratories, contract research
organizations, and other end users. The hospitals segment is estimated to
account for the largest share of the global market during the forecast period.
Growth in the number of hospitals coupled with better accessibility and
availability of test results in hospitals are major factors driving the growth
of this end-user segment.
Market Players
The key players in the Tissue Diagnostics market are F. Hoffman-La Roche (Switzerland), Danaher (US), Thermo Fisher Scientific (US), Abbott Laboratories (US), Agilent Technologies (US), Merck (Germany), Sakura Finetek Japan, Abcam (UK), Becton, Dickinson and Company (US), and QIAGEN (Netherlands).
The key players in the Tissue Diagnostics market are F. Hoffman-La Roche (Switzerland), Danaher (US), Thermo Fisher Scientific (US), Abbott Laboratories (US), Agilent Technologies (US), Merck (Germany), Sakura Finetek Japan, Abcam (UK), Becton, Dickinson and Company (US), and QIAGEN (Netherlands).
View Complete Press
Release @
https://www.marketsandmarkets.com/PressReleases/tissue-diagnostics.asp
https://www.marketsandmarkets.com/PressReleases/tissue-diagnostics.asp
Comments
Post a Comment